Publications
- External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score2021 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study2020 | First Faculty of Medicine
- Determination of Circulating Endothelial Cells and Endothelial Progenitor Cells Using Multicolor Flow Cytometry in Patients with Thrombophilia2019 | First Faculty of Medicine
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study2016 | Publication without faculty affiliation
- Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future2015 | First Faculty of Medicine
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
Loading network view...
